About Delvin Formulations Private Limited
Data last updated:
Delvin Formulations Private Limited was a private limited company based in Chingleput, Tamil Nadu, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 July 2009.
The company was registered with the Registrar of Companies (ROC), Chennai, under CIN U24100TN2009PTC072376. Its GSTIN is 33AADCD1977F1ZT (Tamil Nadu). The company held 10 GST registrations, of which 2 are active.
The company had an authorised share capital of ₹3.25 Cr and a paid-up capital of ₹2.28 Cr. It was led by directors including Shanmugam Muthusamy and Jaganathan Jayaseelan.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at A5 3rd Cross Street Sipcot IT Park, Chingleput, Tamil Nadu.
As per the financials filed for FY 2023, the company reported a revenue of ₹30.87 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹3.45 Cr (net margin 11.2%) and EBITDA of ₹9.49 Cr (EBITDA margin 30.7%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 8% over five years.
The company had about 219 employees on its provident fund (EPFO) records before it was dissolved.
The company was associated with 1 brand: Delvin. As per MCA filings, the company had satisfied charges of ₹27.37 Cr on record. Court records list 5 cases involving the company, including 2 filed by the company and 3 filed against it.
The last known website on record is delvin.in.
Company details
Contact details
Delvin Formulations Private Limited's registered office is in Chingleput, Tamil Nadu. Its website is delvin.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo 5/A5 3rd Cross Street Sipcot IT Park, Siruseri India, Chingleput, Tamil Nadu, India – 603103
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Delvin Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Delvin Formulations is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Delvin Formulations Private Limited, buy the company report.
Financials of Delvin Formulations Private Limited
FY 2023 filings availableDelvin Formulations Private Limited reported revenue of ₹30.87 Cr (up 26% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 26% growth in the latest year. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹30.87 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.49 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.45 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 30.7% | ||||
| Net Profit Margin | 11.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Delvin Formulations Private Limited, buy the company report.
Board of directors of Delvin Formulations Private Limited
Delvin Formulations has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ayyavu Rajavel Also directs: Nuray Chemicals Private Limited, Saimirra Innopharm Private Limited, Delvin Surgicals Private Limited and 5 more | Alternate Director | 13 Aug 2009 | 17 Years 2 Months | As last reported |
| Shanmugam Muthusamy Also directs: Nuray Chemicals Private Limited, Saimirra Innopharm Private Limited, Annamar Pharma LLP and 5 more | Director | 24 Jul 2009 | 17 Years 3 Months | As last reported |
| Jaganathan Jayaseelan Also directs: Durujaya Infrastructure LLP, Nuray Chemicals Private Limited, Clan Laboratories Private Limited and 5 more | Director | 24 Jul 2009 | 17 Years 3 Months | As last reported |
| Bernice Sugirtha | Director | 14 Dec 2020 | 5 Years 10 Months | As last reported |
Peer comparison
Delvin Formulations Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Central Lifecare Private Limited | ₹31.03 Cr (FY 2025) | 5.0% | Mumbai, Maharashtra, India | |||
| Krish Chemicals Private Limited | ₹31.02 Cr (FY 2024) | 4.0% | Sarigam, Gujarat, India | |||
| Delvin Formulations Private Limitedthis company | ₹30.87 Cr (FY 2023) | ₹3.45 Cr | 11.2% | 26.0% | 219 | Chingleput, Tamil Nadu, India |
| Rajshi Farma Private Limited | ₹30.72 Cr (FY 2025) | 4.0% | New Delhi, Delhi, India | |||
| Algen Healthcare Limited | ₹30.69 Cr (FY 2025) | 5.0% | Delhi, India | |||
| Modern Homoeo Distributors Pvt Ltd | ₹30.63 Cr (FY 2024) | 5.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Delvin Formulations Private Limited, buy the company report.
Auditor
Delvin Formulations Private Limited is audited by AR.ANNAMALAI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AR.ANNAMALAI & CO | FY 2023 | 28036 |
Shareholding
The shareholding of Delvin Formulations Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Delvin Formulations Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Oct 2022 | 100624035 | Others | ₹10.44 Cr | Satisfied | |
| 20 May 2019 | 100267035 | Others | ₹94,000 | Satisfied | |
| 14 Feb 2019 | 100243273 | Others | ₹23.5 Lakh | Satisfied | |
| 01 Jun 2018 | 100184732 | Others | ₹23.05 Lakh | Satisfied | |
| 30 Jan 2017 | 100083630 | Hdfc Bank Limited | ₹11.45 Cr | Satisfied |
To see the full charge records of Delvin Formulations Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Delvin Formulations Private Limited has 5 court cases on record: 2 filed by Delvin Formulations, 3 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
| High courts | 2 | 1 | 0 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Jaipur Metro I, Rajasthan | Court case (Complaint) | Filed against the company by Muthoot Fincorp Limited | Disposed |
| High Court, TAMIL NADU | Original application | Filed against the company by Sutherland Healthcare Solutions Pvt. Ltd. | Disposed |
| High Court, TAMIL NADU | Petition | Filed by the company against Peekay Medi Equip Ltd., | Disposed |
| NCLT, Chennai | Insolvency matter | Filed by the company against an individual | Disposed |
| District court, Thrissur, Kerala | Civil suit | Filed against the company by Arban Thrissur Kuries Pvt. Ltd | Disposed |
To see the full case history of Delvin Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Delvin Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Delvin Formulations Private Limited has a workforce of 219 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Delvin Formulations has 10 GST registrations: 2 active and 8 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AADCD1977F1ZT | Tamil Nadu | Active | 01 Jul 2017 |
| 24AADCD1977F1ZS | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Delvin Formulations Private Limited, buy the company report.
Recent activity
Delvin Formulations Private Limited has 4 board changes on record since 2009: 4 appointments. The latest: Bernice Sugirtha was appointed as Director on 14 Dec 2020.
12 earlier events are in the company report.
Frequently asked questions
Delvin Formulations has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Delvin Formulations was a private limited company based in Chingleput, Tamil Nadu, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 July 2009 and is registered under CIN U24100TN2009PTC072376. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Delvin Formulations was incorporated on 24 July 2009. It is registered with the Registrar of Companies, Chennai.
Delvin Formulations had 4 directors:
- Ayyavu Rajavel - Alternate Director
- Shanmugam Muthusamy - Director
- Jaganathan Jayaseelan - Director
- Bernice Sugirtha - Director
The CIN (Corporate Identification Number) of Delvin Formulations is U24100TN2009PTC072376. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Delvin Formulations is at No 5A5 3rd Cross Street Sipcot IT Park, Siruseri India, Chingleput, Tamil Nadu, India – 603103.
Delvin Formulations can be reached through the website delvin.in. Its registered office is in Chingleput, Tamil Nadu, India.
The latest financial statements of Delvin Formulations on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Delvin Formulations is 33AADCD1977F1ZT, registered in Tamil Nadu. The company has 10 GST registrations in all, of which 2 are active and 8 are cancelled or inactive. Other active GSTINs include 24AADCD1977F1ZS (Gujarat).
Delvin Formulations operated in the pharma industry, in the pharmaceutical retailers and distributors segment.
The peers of Delvin Formulations by revenue are Central Lifecare Private Limited, Krish Chemicals Private Limited, Rajshi Farma Private Limited, Algen Healthcare Limited, Modern Homoeo Distributors Pvt Ltd, all in the Pharma industry (Formulations, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).